AquaBounty Technologies

From Wikipedia, the free encyclopedia
Jump to: navigation, search
AquaBounty Technologies Inc.
Industry Biotechnology
Founded 1991[1]
Headquarters Waltham, Massachusetts [1]
Key people
Ronald L. Stotish (President & CEO)

AquaBounty Technologies is a biotechnology company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish.[2] It aims to create products that aim to increase the productivity of aquaculture.[3]


The company has developed hybrid salmon, trout, and tilapia designed to grow faster than traditional fish.

Their hybrid Atlantic salmon incorporates a gene from a Chinook salmon, which bears a single copy of the stably integrated α-form of the opAFP-GHc2 gene construct at the α-locus in the EO-1α line (Ocean Pout AKA Eel).[4] AquaBounty has patented and trademarked this fish as the AquAdvantage salmon, a sterile Atlantic salmon female that can grow to market size in half the time of conventional salmon.[5]

The company also produces antifreeze proteins; and conducts research and development programs related to the commercialization of cryo preservatives and the antifreeze gene constructs.[3]


In 2012, a New York Times article reported the finances of AquaBounty were not in good shape and the company had to reduce staff from 27 to 12.[6] In March 2012, AquaBounty raised US$2 million in new capital, but this would only last until the end of the year.[6]

Georgian investor Kakha Bendukidze owned 47.6% of the company's stock before selling to American synthetic biology firm Intrexon in October 2012. Intrexon put up $500,000 in bridge financing and offered to buy the rest of the company.[5][7] Intrexon acquired majority ownership of Aquabounty in 2013.[8]


  1. ^ a b "Company & History". Retrieved 2011-03-18. 
  2. ^
  3. ^ a b "AquaBounty Technologies Company Overview". Bloomberg Businessweek. Retrieved 2011-03-18. 
  4. ^ Staveley, Jane P. (25 August 2010). "Environmental Assessment for AquAdvantage Salmon" (PDF). Retrieved 2012-10-03. 
  5. ^ a b Pollack, Andrew (December 21, 2012). "Engineered Fish Moves a Step Closer to Approval". The New York Times. 
  6. ^ a b Pollack, Andrew (21 May 2012) An Entrepreneur Bankrolls a Genetically Engineered Salmon. The New York Times, Retrieved 3 October 2012
  7. ^ "Delays put question mark over GM salmon as development company receives bid". December 10, 2012. 
  8. ^ Jacob Bunge (15 December 2015) Firm Bets on Biotech That Changes How Food Is Produced. The Wall Street Journal, retrieved 30 January 2016

External links[edit]